| Bio-Link News |
|
06/6/2017 – Bio-Link Senior Business Development Associate, Dr Gorjana Mitic, has been selected to participate in the Bridge Program…more 23/5/2017 – Bio-Link has been engaged by Kunovus Technologies to facilitate partnering of KT009…more 16/5/2017 – Bio-Link has been engaged by Actinogen Medical to facilitate partnering of Xanamem™…more 04/4/2017 – Bio-Link is pleased to welcome 2 new professionals to the team…more 31/1/2017 – Bio-Link has partnered with Neural Diagnostics in its development of ElectroVestibuloGraphy (EVestG™), a novel neurological disease classifier…more |
| Client News |
|
07/06/2017 – Oncology Venture: new APO010 multiple myeloma trial initiation, clinical and patent strategy validation …more 04/04/2017 – Oncology Venture has announced two major partnering deals…more. 28/03/2017 – Oncology venture – APO010 approved for testing in phase II multiple myeloma trial…more. 14/02/2017 – Neural Diagnostics Pty Ltd, a Melbourne-based medtech developer, have been awarded $2.2M in a 2nd round CRC-P grant…more. |
| Industry News |
|
Fri, Jun 23, 2017
Source: BioSpace |
| Welcome to Bio-Link |
|
Bio-Link is a strategic consulting and biotechnology business development company that works with Australian and international life sciences companies and academic institutions to facilitate deals based on strategic technology analysis and consulting, business development, project management and deal negotiation. Bio-Link also provides technology scouting and representation services for Australian and international companies. Bio-Link has offices in Melbourne and Sydney. Please explore our website to learn more about Bio-Link’s services and client endorsements and our portfolio of client technologies. Follow @BioLinkAus |
Bio-Link employs PatSnap IP Analytics |
Bio-Link is a proud member of
|
